Anzeige
Meldung des Tages: 30 Jahre alte Daten könnten jetzt den nächsten großen Antimon-Fund freilegen

Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
126,20 $
+0,21 $
+0,17%
109,20 € 25.03.26
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
66 %
Index-Zuordnung
Nasdaq Composite Index
Weiter aufwärts? Long handeln - Jetzt mit Hebel 20,95: VJ88BP
Werbung

Illumina News

18.03.26 - PR Newswire
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing PR Newswire
16.03.26 - PR Newswire
Illumina advances preventive genomics through strategic consortium with Veritas Genetics
Illumina advances preventive genomics through strategic consortium with Veritas Genetics PR Newswire
05.03.26 - IT-Times
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
05.03.26 - PR Newswire
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering PR Newswire
01.03.26 - IT-Times
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
27.02.26 - IT-Times
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
27.02.26 - PR Newswire
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Illumina whole-​genome sequencing technology to accelerate rare disease testing in Florida PR Newswire
27.02.26 - IT-Times
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
26.02.26 - IT-Times
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
25.02.26 - PR Newswire
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics PR Newswire
24.02.26 - PR Newswire
Illumina launches TruPath Genome, setting a new standard in genomic insight
Illumina launches TruPath Genome, setting a new standard in genomic insight PR Newswire
23.02.26 - PR Newswire
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility PR Newswire
17.02.26 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
05.02.26 - PR Newswire
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 PR Newswire
03.02.26 - PR Newswire
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally PR Newswire
30.01.26 - PR Newswire
Illumina completes acquisition of SomaLogic
Illumina completes acquisition of SomaLogic PR Newswire
20.01.26 - PR Newswire
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology
Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology PR Newswire
13.01.26 - PR Newswire
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery PR Newswire
13.01.26 - PR Newswire
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 PR Newswire
12.01.26 - PR Newswire
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 PR Newswire

Newssuche

Videos

newspaper
23.03.26 +1,52%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »